Ironwood Pharmaceuticals (IRWD) Other Non-Current Assets (2009 - 2026)

Ironwood Pharmaceuticals has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $4.1 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $4.1 million, down 25.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.1 million (down 25.3% YoY), and the FY2025 annual result was $4.5 million, down 23.99% from the prior year.
• Other Non-Current Assets came in at $4.1 million for Q1 2026 at Ironwood Pharmaceuticals, down from $4.5 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $6.3 million in Q3 2024 to a low of $485000.0 in Q4 2022.
• The 5-year median for Other Non-Current Assets is $3.9 million (2023), against an average of $3.3 million.
• Across the five-year window, Other Non-Current Assets slumped 49.21% in 2023 and surged 1132.35% in 2024, its largest moves.
• Ironwood Pharmaceuticals' Other Non-Current Assets stood at $485000.0 in 2022, then soared by 643.92% to $3.6 million in 2023, then surged by 64.16% to $5.9 million in 2024, then retreated by 23.99% to $4.5 million in 2025, then fell by 8.11% to $4.1 million in 2026.
• The last three Other Non-Current Assets figures came in at $4.1 million (Q1 2026), $4.5 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.